I-Buscopan (i-hyoscine butylbromide) imithi e- antispasmodic esetshenziselwa ukuphatha ubuhlungu besisu kanye nama-cramps avela ku- irritable bowel syndrome (i-IBS), kanye nezikhwama zokuya esikhathini.
Indlela Esebenza ngayo
I-Buscopan ihluke kwezinye izidakamizwa ze-antispasmodic ngoba ayiweleli umgoqo wegazi / wengqondo kanye nemikhawulo encane yomuthi ithola indlela yayo eya egazini.
Kunalokho, i-Buscopan isebenza endaweni yangakini emisipha esiswini ukuze kuvinjelwe ukuqhuma kwezidakamizwa. Inzuzo yalolu umehluko yukuthi igweme imiphumela emibi yesimiso se-system njengobuthongo noma isiyezi.
Ukuphumelela
Ukuhlaziywa kwe-meta okwenziwe ukuhlola ukusebenza kwezinhlelo zokwelapha ze- IBS kwaphawula izifundo ezintathu zokwelashwa ezibonisa ukuthi iBuscopan yayisebenza kangcono kune-placebo ekunciphiseni izimpawu ze-IBS. Ucwaningo olwengeziwe lwemitholampilo luye lwabona ukuthi iBuscopan ibekezelela kahle imiphumela emibi. Kodwa-ke, isifundo esetshenziswa iziguli ezitholakale "ubuhlungu besisu esiswini", kodwa hhayi i-IBS, sathola ukuthi i-acetaminophen yayisebenza kahle njengoba iBuscopan iqhathaniswa ne-placebo.
I-Buscopan njengamanje ayidabuli e-United States kodwa ingavame ukuphakanyiswa odokotela ngaphandle kwe-US
Ukuthatha i-Buscopan:
- Amaphilisi e-Buscopan kufanele athathwe, angahlosiwe.
- Qinisekisa ukuphuza ingilazi yamanzi uma uthatha i-Buscopan.
Imithombo:
Ford, et.al. "Impumelelo ye-fiber, i-antispasmodics, namafutha we-peppermint ekwelapheni isifo sofuba esiyingozi: ukubuyekezwa okuhlelekile nokuhlaziywa kwe-meta" BMJ 2008 337: a2313.
U-Tytgat, G. "I-Hyoscine butylbromide: ukubuyekezwa kokusetshenziswa kwayo ekwelapheni ukwakhiwa kwesisu nobuhlungu." " Izidakamizwa 2007 67: 1343-57.
U-Mueller-Lissner, S. "Indawo ye-Placebo- nokuhlola okulawulwa yi-paracetamol ekusebenzeni nokubekezela kwe-hyoscine butylbromide ekwelapheni iziguli ezinezinhlungu eziphindaphindiwe zesisu" I- Alimentary Pharmacology and Therapeutics 2006 23: 1741 - 1748.